Booster Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $5M

  • Investors
  • 5

Booster Therapeutics General Information

Description

Operator of a biotech company developing drug modalities to eliminate toxic accumulation. The company targets a cellular system that regulates and maintains cellular homeostasis and reinstates balance within cells, enabling healthcare professionals to prevent and treat diseases of aging.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Berliner Strasse 80-82
  • 13189 Berlin
  • Germany
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Berliner Strasse 80-82
  • 13189 Berlin
  • Germany

Booster Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Booster Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 13-Nov-2025 $5M Completed Clinical Trials - Phase 1
2. Seed Round 10-Oct-2024 Completed Clinical Trials - Phase 1
1. Seed Round 27-Aug-2021 Completed Startup
To view Booster Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Booster Therapeutics Patents

Booster Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025259603-A1 Pyrrolidine compounds as proteasome stimulators Pending 18-Apr-2024
WO-2025219559-A1 Pyrrolidine compounds as proteasome stimulators Pending 18-Apr-2024
EP-4147723-A1 Bifunctional molecules as proteasome stimulators for improved targeted protein degradation, and their uses as targeted boosting degraders (tarbods) Inactive 09-Sep-2021
EP-4398941-A1 Bifunctional molecules as proteasome stimulators for improved targeted protein degradation, and their uses as targeted boosting degraders (tarbods) Pending 09-Sep-2021
US-20250121068-A1 Bifunctional molecules as proteasome stimulators for improved targeted protein degradation, and their uses as targeted boosting degraders (tarbods) Pending 09-Sep-2021 A61K47/545
To view Booster Therapeutics’s complete patent history, request access »

Booster Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Booster Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Michael J. Fox Foundation Limited Partner
Korify Capital Venture Capital Minority
Novo Holdings Venture Capital Minority
Apollo Health Ventures Venture Capital Minority
Infinitas Capital Family Office Minority
To view Booster Therapeutics’s complete investors history, request access »

Booster Therapeutics FAQs

  • When was Booster Therapeutics founded?

    Booster Therapeutics was founded in 2020.

  • Where is Booster Therapeutics headquartered?

    Booster Therapeutics is headquartered in Berlin, Germany.

  • What is the size of Booster Therapeutics?

    Booster Therapeutics has 8 total employees.

  • What industry is Booster Therapeutics in?

    Booster Therapeutics’s primary industry is Drug Discovery.

  • Is Booster Therapeutics a private or public company?

    Booster Therapeutics is a Private company.

  • What is Booster Therapeutics’s current revenue?

    The current revenue for Booster Therapeutics is .

  • How much funding has Booster Therapeutics raised over time?

    Booster Therapeutics has raised $15M.

  • Who are Booster Therapeutics’s investors?

    Michael J. Fox Foundation, Korify Capital, Novo Holdings, Apollo Health Ventures, and Infinitas Capital have invested in Booster Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process